196 filings
Page 8 of 10
8-K/A
crnw9jhg cr
9 Sep 15
Departure of Directors or Certain Officers
12:00am
8-K
3gzmn4el3ov
9 Sep 15
Departure of Directors or Certain Officers
12:00am
8-K
65s7z3eu9yi5rs2ag8x8
14 Aug 15
Departure of Directors or Certain Officers
12:00am
8-K
y8znnwwah8m
11 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
kn4 y0w96
10 Aug 15
Puma Biotechnology Reports Second Quarter 2015
12:00am
8-K
56k5rfo8exry8v3
11 Jun 15
Departure of Directors or Certain Officers
12:00am
8-K
je1rwygws1i i38
1 Jun 15
Puma Biotechnology Announces Phase III Trial of PB272 in Extended Adjuvant
12:00am
8-K
r5es752gq3ky85pbsz3
11 May 15
Puma Biotechnology Reports First Quarter 2015 Financial Results
12:00am
8-K
4cfj9lk
14 Apr 15
Other Events
12:00am
8-K
qtlxs8 oz8
10 Mar 15
Other Events
12:00am
8-K
ugga0 e3krk
2 Mar 15
Puma Biotechnology Reports Fourth Quarter and Full Year
12:00am
8-K
2ryvslkmh a795b
22 Jan 15
Other Events
12:00am
8-K
8k22iebwc
12 Dec 14
Puma Biotechnology Announces Positive Interim PB272 (Neratinib) Phase II Data
12:00am
8-K
6yoytgr s39ecnk7sh
3 Dec 14
Puma Biotechnology Updates Timeline for Filing New Drug Application
12:00am
8-K
3urlnxly8r e4
20 Nov 14
Departure of Directors or Certain Officers
12:00am
8-K
rr2zbgdi r84vo5m
13 Nov 14
Puma Biotechnology Announces Positive Top Line Results from PB272 Phase II
12:00am
8-K
7sdsd4okekekc
10 Nov 14
Puma Biotechnology Reports Third Quarter 2014
12:00am
8-K
vbtrzm w8fwv87v16mlj
29 Sep 14
Puma Biotechnology Announces Positive Initial Results from PB272
12:00am
8-K
n991fa h43py973sh3
3 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K
ij2fk jdupgkehlyowb3
11 Aug 14
Puma Biotechnology Reports Second Quarter 2014
12:00am